Actively Recruiting
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
Led by Liquid I.V. · Updated on 2024-07-29
16
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
Sponsors
L
Liquid I.V.
Lead Sponsor
U
University of Memphis
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the clinical trial is to evaluate the efficacy of two novel hydration products on rehydration following exercise.
CONDITIONS
Official Title
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adults aged 18 to 49 years
- In good general health with no active or uncontrolled diseases or conditions
- Able to drink the assigned amount of fluid at each visit
- Body mass index (BMI) between 17.0 and 29.9 kg/m2
- Exercise regularly, between 150 and 500 minutes per week, and willing to maintain this level during the study
- Able to maintain exercise status throughout the study
- Peak VO2 at screening must be at least 60% of age and gender matched norms
- Normal or acceptable vital signs (blood pressure and heart rate) at screening
- Individuals with childbearing potential must agree to urine pregnancy tests on each trial day
- Able to understand and consent to the study and complete study procedures
You will not qualify if you...
- Female participants who are pregnant, lactating, or planning pregnancy during the study
- Diagnosed with diabetes
- Weigh 80 pounds (36.3 kg) or less at any visit
- Positive answers on screening questionnaire
- History of celiac disease, chronic pancreatitis, steatorrhea, unstable thyroid disease, major affective disorder, recent psychiatric hospitalization, immune disorders (e.g., HIV/AIDS), or cancer (except certain localized skin or cervical cancers)
- Use of dietary supplements affecting hydration within 30 days before baseline visit
- Consumption of more than two alcoholic drinks per day
- Use of inhalable or smokable products (cigarettes, vaporizers, cannabis) within 30 days before first dose or during study
- Medical conditions affecting ability to exercise or drink prescribed fluids
- Tobacco smoking
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Memphis
Memphis, Tennessee, United States, 38152
Actively Recruiting
Research Team
M
Michael Lelko, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here